Last reviewed · How we verify
Hypophosphatemia
Approved treatments
- Osmoprep · Salix Pharms
- Perikabiven In Plastic Container · Fresenius Kabi
- Dichystrolum
Dichystrolum works by activating the Vitamin D3 receptor to increase calcium levels in the body. - Calcijex · Esjay Pharma
- Rayaldee
Rayaldee works by increasing the levels of active vitamin D in the body. - Rocaltrol · Shandong University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hypophosphatemia patent landscape — cliff calendar, originator estates, attackable patents
- Hypophosphatemia treatment landscape brief
- Hypophosphatemia treatment updates RSS
Frequently asked questions about Hypophosphatemia
What drugs treat Hypophosphatemia?
Tracked treatments include Osmoprep, Perikabiven In Plastic Container, Dichystrolum, Calcijex, Rayaldee, Rocaltrol.
What is the treatment for Hypophosphatemia?
Standard treatment for Hypophosphatemia includes Osmoprep, Perikabiven In Plastic Container, Dichystrolum, Calcijex, Rayaldee. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hypophosphatemia patent cliff · Hypophosphatemia CI report
- Treatment: Osmoprep · Salix Pharms
- Treatment: Perikabiven In Plastic Container · Fresenius Kabi
- Treatment: Dichystrolum
- Treatment: Calcijex · Esjay Pharma
- Treatment: Rayaldee
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing